期刊文献+

DENA诱导大鼠肝细胞癌过程中明胶酶A表达的动态变化 被引量:1

原文传递
导出
出处 《中华肝胆外科杂志》 CAS CSCD 2005年第1期58-59,共2页 Chinese Journal of Hepatobiliary Surgery
基金 广东省自然科学基金课题(编号:974053)
  • 相关文献

参考文献4

  • 1强家模,叶红,谢弘.大鼠肝癌模型CBRH-3的建立及其生物学特性[J].动物学报,1996,42(2):166-171. 被引量:9
  • 2Musso O, Theret N, Pierre J, et al. Insitu detection of matrix metalloproteinase-2 (MMP-2) and the metalloproteinase inhibitor (TIMP-2) transcripts in human primary hepatocellular carcinoma and in liver metastasis. J Hepatol, 1997. 26:593-605.
  • 3Yamamoto H, Itoh F, Adachi Y, et al.Relation of enhanced secretion of active matrix metalloproteinase with tumor spread in human hepacellular carcinoma.Gastroentrology, 1997,112 : 1990-1296.
  • 4Stetler-Stevenson WG, Liotta LA, Kleiner DE. Extracellular matrix 6 : role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J,1993,7:1434-1441.

二级参考文献2

  • 1强家模,实验生物学报,1981年,4卷,1期,65页
  • 2强家模,实验生物学报,1978年,1卷,1期,87页

共引文献8

同被引文献12

  • 1何勇,周峻,窦科峰.转染HGF基因对肝细胞的生物学效应[J].中华肝胆外科杂志,2005,11(2):118-120. 被引量:3
  • 2Yoo GH, Piechocki MP, Oliver J, et al. Enhancement of Adp53 therapy with doeetaxel in head and neck cancer. Laryngoscope, 2004,114 : 1871-1879.
  • 3Small EJ, Carducci MA, Burke JM, et al. A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer. Mol Ther, 2006,14 : 107-117.
  • 4Zheng JN, Pei DS, Mao LJ, et al. Inhibition of renal cancer cell growth in vitro and in vivo with oncolyuc adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA. Cancer Gene Ther, 2009,16 : 20-32.
  • 5Nakagawa T, Tanaka H, Shirakawa T, et al. Cyclooxygenase 2 promoter-based replication-selective adenoviral vector for hypopharyngeal cancer. Arch Otolaryngol Head Neck Surg, 2009, 135 : 282-286.
  • 6Fujiwara T. Telomerase-specifie virotherapy for human squamous cell carcinoma. Expert Opin Biol Ther, 2009,9:321-329.
  • 7Ren XW, Liang M, Meng X, et al. A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepat6cellular carcinoma. Cancer Gene Ther, 2006,13;159-168.
  • 8Gopalan B, Shanker M, Chada S, Ramesh R. IL-24/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo. Mol Cancer, 2007,6:11.
  • 9Zheng M, Bocangel D, Doneske B, et al. Human interleukin 24 (IL-24/IL-24) protein kil.ls breast cancer ceils via the IL-20 receptor and is antagonized by IL-10. Cancer Immunoi Immunother, 2007,56 :205-215.
  • 10Pataer A, HUW, Xiaolin L, et al. Adenoviral endoplasmic reticulum-targeted IL-24/interleukin-24 vector enhances human cancer cell killing. Mol Cancer Ther, 2008,7:2528-2535.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部